Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
Hannah Painter, Sasha E. Larsen, Brittany D. Williams, Hazem F. M. Abdelaal, Susan L. Baldwin, Helen A. Fletcher, Andrew J. Fiore-Gartland, Rhea N. Coler
The paper evaluates human-derived tuberculosis disease risk biosignatures for their predictive fidelity across preclinical models and tissues using public datasets.
mSphere · Dec 9, 2024Peer-reviewedImmunology